Central Nervous System Disorders and Structure

Glutamate and Brain Injury

  • Glutamate is an excitatory neurotransmitter crucial for learning, memory, and other brain functions.
  • After brain injury, oxygen deprivation causes neuron disintegration, leading to excessive release of glutamate.
    • Under such conditions, glutamate acts as an excitotoxin, killing surrounding cells.

Stroke Treatment

  • Primary treatment for stroke includes tissue plasminogen activator (tPA), used to dissolve blood clots in the brain.
  • Mechanical devices can also be used to extract clots mechanically.

Degenerative Brain Disorders

Alzheimer’s Disease (AD)

  • Definition: Progressive degenerative disease leading to dementia, particularly common in individuals over 65.
  • Symptoms include:
    • Memory loss, especially recent events.
    • Reduced attention span and disorientation.
    • Emotional changes, leading to irritability and confusion.
  • Prevalence: Represent about 50% of nursing home residents; impacts up to 15% of over-65s and is a major cause of death for half of those over 85.
  • Two key features:
    • Plaques: Aggregates of beta-amyloid peptide formed through the cleavage of amyloid precursor protein (APP). Excess beta-amyloid is believed to be toxic.
    • Neurofibrillary Tangles: Formed by misfolded tau protein; disrupt transport mechanisms within neurons leading to cell death.
  • Misfolded proteins within plaques and tangles spread throughout the brain regions, contributing to varying dementia types and progression.
    • Areas particularly affected:
    • Hippocampus, basal forebrain, and cortical association regions.
  • A decrease in acetylcholine production is noted, particularly affecting neural function; drugs that inhibit its breakdown can marginally improve cognitive function.

Parkinson’s Disease

  • Definition: Degenerative disorder from the loss of dopamine-producing neurons in the substantia nigra.
  • Characteristics:
    • Resting tremors (often presented as "pill-rolling"), stooped posture, shuffling gait, and slowed movement initiation.
  • Risk increases with age; underlying cause remains unidentified but might involve mitochondrial dysfunction and other protein degradation issues.
  • Treatments:
    • L-Dopa: Helps increase dopamine levels; however, efficacy diminishes as neurons die.
    • Combining L-Dopa with dopamine breakdown inhibitors can extend its effectiveness.
    • Deep brain stimulation can alleviate symptoms by shutting down abnormal activity in the brain.
    • Gene therapy and stem cell implantation present future treatment possibilities.

Huntington’s Disease

  • Definition: Fatal hereditary disorder manifesting in middle age due to accumulation of mutant huntingtin protein in brain cells.
  • Symptoms:
    • Characterized by chorea (wild, jerky movements) that appear voluntary but are not.
    • Severe mental decline occurs in late stages.
  • The disease progresses rapidly, typically leading to death within 15 years.
  • Treatment includes medications that block dopamine effects, contrasting with Parkinson’s disease treatments that enhance dopamine effects.

Diagnostic Procedures for CNS Dysfunction

  • Reflex tests, like knee-jerk responses, assess neural function; abnormal responses may indicate severe conditions (e.g., intracranial hemorrhage, multiple sclerosis).
  • Advanced imaging techniques, including CT, MRI, and PET scans, have improved the ability to identify brain lesions, tumors, plaques, and Alzheimer’s-related tissue.
  • Transitional Ischemic Attack (TIA): A temporary reduction of blood flow to the brain that may present similarly to a stroke but does not cause permanent damage.

Anatomy of the Spinal Cord

  • Extends from the foramen magnum to the L1 or L2 vertebra.
  • Measures approximately 42 cm in length and 1.8 cm in thickness; acts as a conduit between the brain and the rest of the body.
  • Surrounded by protective structures (bones, meninges, cerebrospinal fluid).
  • Features:
    • Dorsal and ventral horns comprise gray matter; the white matter surrounds the gray matter and contains ascending and descending tracts.
  • The spinal cord has enlargements at cervical and lumbar regions related to limb innervation.
  • Consists of 31 pairs of spinal nerves; spinal nerve segments generally do not align perfectly with vertebrae due to differential growth rates during development.
  • Cauda equina refers to the collection of nerve roots at the end of the vertebral column, resembling a horse’s tail.

Key Distinctions in Spinal Cord Structure:

  1. Gray Matter:
    • Contains cell bodies (interneurons and motor neurons).
    • Dorsal and ventral horns serve different functional roles.
  2. White Matter:
    • Organized into ascending and descending tracks, responsible for relaying information.